 |
Home > About
Biospace > Overview |
 |
With the continuing increase in standard
of living, the focus on quality of life has intensified in recent
times. In particular, obesity is a health issue featured in the
mass media that has been warranting more attention than ever
before. More and more people are coming to realize that obesity
is a disease that results in other more substantial health problems
that otherwise could have been avoided. Due to this correlation,
interest in obesity treatment is on the rise.
Biospace’s body composition analyzer, the Inbody, stands at the center of this anti-obesity movement.
Up until recently, most people believed that obesity could be avoided or reversed by simply losing a certain number of pounds of body weight. With the development of the InBody, the terms 'body composition' and 'body fat' have come to be recognized as reliable measures of obesity. Individuals now know that the prevention of obesity depends on the reduction and control of body fat. Biospace’s trailblazing activitites in this field are evident in the “InBody Test”, a commonly given body composition analysis that has reciently increased in popularity.
InBody, made by Biospace, is the world’s first body composition
analysis device that uses an 8-point tactile electrode method.
Having received FDA approval in the United States and approval
of other countries’ authorities, such as in Japan, this product’s
high quality and accuracy have been validated.
With the unparalleled
performance of the InBody in the domestic obesity diagnosis market
Biospace has solidified its foundation as a professional medical
device manufacturer. The plan for the future entails the company’s
ongoing development and expansion into a comprehensive professional
health care organization.
In particular, the company is striving
to achieve superior competitiveness that will facilitate success
in advanced markets around the world, such as those in the United
States, Japan, and Europe.
|
|
 |
Biospace, Inc. |
|
 |
July 01, 2004 |
|
 |
Kichul Cha |
|
 |
Office |
8820 Wilshire
Blvd., Suite 310, Beverly Hills, CA 90211 |
|
 |
310 - 358
- 0360 |
|
|
 |
310 - 358
- 0370 |
|
|